Are there specific patient populations in which the INTERGROWTH-21 growth curve is preferred compared to the Hadlock curve for fetal growth assessment?

In South Asian populations and preterm infants, evidence suggests that the INTERGROWTH-21 curve may offer advantages over the Hadlock curve. However, robust clinical trials are needed to confirm these findings and guide their specific application in diverse settings.